These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 19200778)
1. No apparent difference in the prevalence of parvovirus B19 infection between chronic fatigue syndrome patients and healthy controls in Japan. Kato YH; Yamate M; Tsujikawa M; Nishigaki H; Tanaka Y; Yunoki M; Kuratsune H; Watanabe Y; Ikuta K J Clin Virol; 2009 Mar; 44(3):246-7. PubMed ID: 19200778 [No Abstract] [Full Text] [Related]
2. Chronic fatigue syndrome and arthralgia following parvovirus B19 infection. Kerr JR; Bracewell J; Laing I; Mattey DL; Bernstein RM; Bruce IN; Tyrrell DA J Rheumatol; 2002 Mar; 29(3):595-602. PubMed ID: 11911112 [TBL] [Abstract][Full Text] [Related]
3. Successful intravenous immunoglobulin therapy in 3 cases of parvovirus B19-associated chronic fatigue syndrome. Kerr JR; Cunniffe VS; Kelleher P; Bernstein RM; Bruce IN Clin Infect Dis; 2003 May; 36(9):e100-6. PubMed ID: 12715326 [TBL] [Abstract][Full Text] [Related]
4. [Parvovirus B19 infection and its clinical picture]. Dudina KR; Znoĭko OO; Iushchuk ND Ter Arkh; 2007; 79(11):75-8. PubMed ID: 18219981 [No Abstract] [Full Text] [Related]
5. Severe transfusion-transmitted parvovirus B19 infection in a naive immunocompromised patient. Brodin-Sartorius A; Mekki Y; Pastural M; Billaud G; Daoud S; Chauvet C; Touraine JL; Lina B; Morelon E; Thaunat O Transpl Infect Dis; 2011 Feb; 13(1):97-8. PubMed ID: 20636481 [No Abstract] [Full Text] [Related]
12. Meningoencephalitis with persistent parvovirus B19 infection in an apparently healthy woman. Bonvicini F; Marinacci G; Pajno MC; Gallinella G; Musiani M; Zerbini M Clin Infect Dis; 2008 Aug; 47(3):385-7. PubMed ID: 18558883 [TBL] [Abstract][Full Text] [Related]
13. Population-based study on the seroprevalence of parvovirus B19 in Amsterdam. van Rijckevorsel GG; Sonder GJ; Schim van der Loeff MF; van den Hoek JA J Med Virol; 2009 Jul; 81(7):1305-9. PubMed ID: 19475607 [TBL] [Abstract][Full Text] [Related]
15. Pathophysiological mechanisms of parvovirus B19 infection. Noutsias M; Pankuweit S; Maisch B J Clin Microbiol; 2009 Jul; 47(7):2358-9; author reply 2359. PubMed ID: 19574588 [No Abstract] [Full Text] [Related]
16. Fulminant myocarditis associated with parvovirus B19 infection in a child. Dina J; Vabret A; Rambaud C; Checoury A; Gouarin S; Petitjean J; Freymuth F J Clin Virol; 2008 May; 42(1):70-1. PubMed ID: 18313977 [No Abstract] [Full Text] [Related]
17. [Neutropenia and/or thrombocytopenia due to acute parvovirus B19 infection]. Frotscher B; Salignac S; Morlon L; Bonmati C; Jeulin H; Venard V; Lecompte T Ann Biol Clin (Paris); 2009; 67(3):343-8. PubMed ID: 19411238 [TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of human parvovirus B19 infection in an urban population in Malaysia. Ooi SL; Hooi PS; Chua BH; Lam SK; Chua KB Med J Malaysia; 2002 Mar; 57(1):97-103. PubMed ID: 14569725 [TBL] [Abstract][Full Text] [Related]
20. Detection of herpesviruses and parvovirus B19 in gastric and intestinal mucosa of chronic fatigue syndrome patients. Frémont M; Metzger K; Rady H; Hulstaert J; De Meirleir K In Vivo; 2009; 23(2):209-13. PubMed ID: 19414405 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]